Fidaxomicin Use and Clinical Outcomes for Clostridium Difficile–Associated Diarrhea

Infectious Diseases in Clinical Practice - United States
doi 10.1097/ipc.0000000000000181
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Fidaxomicin for Clostridium Difficile-Associated Diarrhoea

Clinical Drug Investigation
MedicinePharmacology
2012English

Clostridium Difficile-Associated Diarrhea

Infection Control and Hospital Epidemiology
EpidemiologyInfectious DiseasesMicrobiology
1990English

Clindamycin Restriction Decreases Clostridium Difficile-Associated Diarrhea

Infection Control and Hospital Epidemiology
EpidemiologyInfectious DiseasesMicrobiology
1998English

Studies on Diarrhea in Equine Associated With Clostridium Difficile and Clostridium Perfringens Infection

Alexandria Journal of Veterinary Sciences
2015English

Molecular Analysis of Clostridium Difficile Strains Isolated From 18 Cases of Recurrent Clostridium Difficile-Associated Diarrhea

Journal of Clinical Microbiology
Microbiology
2003English

Recurrent Clostridium Difficile Colitis in Elderly: The Role of Fidaxomicin

Clinical Management Issues
MedicineAccountingManagementBusiness
2014English

An Outbreak of Clostridium Difficile-Associated Diarrhea in Piglets in Brazil

Semina:Ciencias Agrarias
AgriculturalBiological Sciences
2013English

US-based National Surveillance for Fidaxomicin Susceptibility of Clostridioides Difficile (Formerly Clostridium) Associated Diarrheal Isolates From 2013-2016

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Current and Emerging Management Options for Clostridium Difficile Infection: What Is the Role of Fidaxomicin?

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy